MarketPulse

portfolio rotation

5 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

Major Investor Trims $104M Nuvalent Stake as Cancer Drug Developer Surges 30%

Vestal Point Capital sold $103.93M in Nuvalent shares, reducing exposure despite company's 30% rally and $1.4B cash position awaiting 2026 FDA decisions.
ABBVNUVLTERNBMRNFDA approvalbiotech
The Motley FoolThe Motley Fool··Beth Mckenna

Market Turbulence Erupts as Geopolitical Tensions Reshape Asset Allocation

U.S.-Israeli military action kills Iranian Supreme Leader, triggering stock futures decline and surge in oil, gold prices as investors rotate toward defensive sectors.
NVDAPLTRLMTRTXGD+2market volatilityoil prices
The Motley FoolThe Motley Fool··Adam Spatacco

Thiel Macro Exits Major Tech Holdings, Moves to Cash Position

Thiel Macro liquidated entire tech portfolio including Nvidia, Tesla, Microsoft, and Apple, moving to cash amid AI competition, macro uncertainty, and geopolitical tensions.
NVDAMETAMSFTAMZNGOOG+4cash positionAI stocks
The Motley FoolThe Motley Fool··John Ballard

Mesirow Financial Establishes $131.8M Position in Akre Focus ETF

Mesirow Financial invested $131.8M in Akre Focus ETF, representing 2.7% of AUM, signaling a strategic shift away from mega-cap tech toward undervalued growth opportunities.
MSFTGOOGGOOGLAKREAAPLAkre Focus ETFquality stocks
BenzingaBenzinga··Erica Kollmann

Druckenmiller Shifts Portfolio Away From Tech Toward Brazil and Value Plays

Druckenmiller reduces tech holdings, adds $113M Brazil position via EWZ ETF. Shifts portfolio toward value plays and financial services from mega-cap growth.
METASNDKGOOGGOOGLRSP+4emerging marketsvalue investing